MADCAM1 and congenital secretory chloride diarrhea 1: Our findings suggest that blocking α4β7/MAdCAM-1-mediated recruitment of α4β7+ T cells to the liver may represent a novel therapeutic strategy to slow or prevent fibrosis progression in CLD.